Trial NCT02573935

View at ClinicalTrials.gov 
Org. Study IDs: DMSG 03/14
Secondary IDs: 2014-002187-32

Last trial update was posted on 2016-09-20

MeSH Interventions

Clarithromycin

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Suspected side effects to the combination of clarithromycin and VCD (bortezomib, cyclophosphamide and dexamethasone)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID